Rabies - Risk of exposure and current trends in prevention of human cases

Vaccine

Volumn 17, Issue 13-14, 1999, Pages 1742-1749

  Haupt, Wolfgang ^a  

^a Chiron Behring GmbH & Co   (Germany)

Author keywords

Epidemiology; Human cases; Rabies; Treatment; Vectors

Indexed keywords

RABIES VACCINE;

CONFERENCE PAPER; DEVELOPING COUNTRY; ETHIOPIA; GEOGRAPHIC DISTRIBUTION; HUMAN; INFECTION PREVENTION; INFECTION RISK; INTRADERMAL DRUG ADMINISTRATION; INTRAMUSCULAR DRUG ADMINISTRATION; MORTALITY; PRIORITY JOURNAL; RABIES; WORLD HEALTH ORGANIZATION;

ANIMALS; DOGS; HUMANS; RABIES; RISK; TREATMENT FAILURE;

EID: 0344177531     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(98)00447-2     Document Type: Conference Paper

References (18)

1. Fekadu M., Endeshaw E., Alemu W.et al. Possible human-to-human transmission of rabies in Ethiopia. Ethiop Med J. 34:1996;123-127.
2. WHO Geneva. World rabies survey 31.
3. Finkel E. Lyssavirus death occurs in Australia. Lancet. 348:1996;1437.
4. Tideman C.R., Vardon M.J., Nelson J.E.et al. Health and conservation implications of Australian bat Lyssavirus. Austr. Zoologist. 30:1997;369-376.
5. WHO Collaboration Center for Rabies Surveillance and Research, Tuebingen, Rabies Bulletin Europe, IV 1997.
6. WHO Collaboration Center for Rabies Surveillance and Research, Tuebingen, Rabies Bulletin Europe, IV 1996.
7. Warrel M.J., Warrel D.A., Suntharamasai P.et al. An economical regimen of human diploid cell strain anti-rabies vaccine for post-exposure prophylaxis. Lancet. ii:1983;301-304.
8. Suntharamasai P., Warrel M.J., Viravan C.et al. Purified chick embryo cell rabies vaccine: Economical multisite intradermal regimen for post-exposure prophylaxis. Epidem Inf. 99:1987;755-765.
9. Phanupak P., Phakamatz P., Sirivichayakul S.et al. Humoral and cell-mediated immune response to various economical regimens of purified vero cell rabies vaccine. Asian Pac J Allergy Immunol. 5:1987;33-37.
10. Briggs D.J., Schwenke J.R. Longevity of rabies antibody titers in recipients of human diploid cell rabies vaccine. Vaccine. 10:1992;125.
11. Sabchareon A. Immunogenicity of rabies vaccine ID in young children in Thailand, paper presented at the WHO consultation on intradermal application of human rabies vaccine, WHO Geneva, March 13-14, 1995.
12. WHO Geneva, WHO recommendation on rabies post-exposure treatment and the correct technique for intradermal immunization against rabies, WHO/EMC/ZOO. 96.6.
13. Kosiprapa C., Wimalratna O., Chomchey P.et al. Problems with rabies post-exposure management: A survey of 499 public hospitals in Thailand. J Travel Med. 5:1998;30-32.
14. Ackman D. Human rabies cases in the US. Abstract emerging issues in rabies prevention, Workshop, March 1998.
15. Tuttle MD. America's neighborhood bats. Univ. of Texas Press, 1990.
16. Dietzschold B, Hooper DC. Human diploid cell culture rabies vaccine (HDCV) and purified chick embryo cell culture rabies vaccine (PCECV) both confer protective immunity against infection with the silver-haired bat rabies virus strain (SHBRV). Vaccine 1998;16:1656-1659.
17. WHO Geneva, WHO Expert Committee on Rabies. WHO Technical Report Series 824.
18. Sehgal S. Paper presented at the WHO consultation on intradermal application of human rabies vaccines, WHO Geneva, June 3-5, 1996.